Tech Company Financing Transactions
scPharmaceuticals Funding Round
scPharmaceuticals closed a $3.6 million funding round on 2/4/2016. Backers included private investors.
Transaction Overview
Company Name
Announced On
2/4/2016
Transaction Type
Debt
Amount
$3,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 12 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2400 District Ave. 310
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Website
Email Address
Overview
scPharmaceticals (NASDAQ: SCPH) is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two component delivery system suitable for patient self-administration.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Tucker
Chief Financial Officer
Troy Ignelzi
Chief Operating Officer
Abraham Ceesay
Browse more venture capital transactions:
Prev: 2/4/2016: ZenDrive venture capital transaction
Next: 2/4/2016: Future Motion venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs